Inflammatory Bowel Disease Treatment Market Expected To Encourage Expansion At A CAGR Of 4.4% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.
San Francisco, 7 August 2019: The Report Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Ulcerative Colitis, Crohn’s Disease), By Route of Administration, By Distribution Channel, And Segment Forecasts, 2019 – 2026 The global inflammatory bowel disease treatment market size is expected to reach USD 22.4 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.4% CAGR during the forecast period. Increasing prevalence and incidence of Crohn’s disease and ulcerative colitis is one of the major factors contributing to the market. According to a study published in the NCBI in 2019, the North America incidence of inflammatory bowel disease (IBD) treatment is around 2.2 to 19.2 cases per 100,000 persons per year. It was also published that around 238 per 100,000 population in U.S. were suffering from ulcerative colitis. Furthermore, The Centers for Disease Control and Prevention (CDC) estimates that in U.